|
Dr. Jeffrey Gelfand is the Executive Director of the Sheldon and Miriam Adelson Medical Research Foundation an organization focused on cancer research and cancer immunotherapy. In addition Dr. Gelfand is the Senior Advisor for International Medical Affairs at Partners HealthCare System the parent organization for the Massachusetts General Hospital as well as a Senior Attending Physician at MGH and a Professor at Harvard Medical School. Until recently Dr. Gelfand served as Director of the International Program of the Center for Integration of Medicine and Innovative Technology (CIMIT) a consortium of M.I.T. The Charles Stark Draper Laboratory the Massachusetts General Hospital and the Brigham and Women's Hospital. CIMIT's focus is on the development of innovative approaches to medical problems by collaborative research between engineers and physicians. Previously he had been Dean for Research at Tufts University School of Medicine and Senior Vice President for Research and Technology at the New England Medical Center positions he assumed in March 1998. From 1994 to 1998 Dr. Gelfand was the Sheldon M. Wolff MD Professor of Medicine and Chairman of the Department of Medicine of Tufts University School of Medicine and Physician-in-Chief at the New England Medical Center. A 1971 graduate of Tufts University School of Medicine Dr. Gelfand subsequently did his clinical training at the Johns Hopkins Hospital and at the National Institutes of Health. He is board-certified in Internal Medicine Infectious Diseases and Clinical Immunology and Allergy. Dr. Gelfand is performing services for Novelos pro bono thus he is not receiving any cash stock or stock option compensation from Novelos. | 